Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia

[1]  S. Kuroda,et al.  Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the Rat , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Ping-An Li,et al.  Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat , 1998, Brain Research.

[3]  T. Wieloch,et al.  Cyclosporin A, But Not FK 506, Protects Mitochondria and Neurons against Hypoglycemic Damage and Implicates the Mitochondrial Permeability Transition in Cell Death , 1998, The Journal of Neuroscience.

[4]  E. Neuwelt,et al.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. , 1998, Neurosurgery.

[5]  S. Kuroda,et al.  The Immunosuppressant Drug FK506 Ameliorates Secondary Mitochondrial Dysfunction Following Transient Focal Cerebral Ischemia in the Rat , 1997, Neurobiology of Disease.

[6]  S. Butcher,et al.  Neuroprotective Actions of FK506 in Experimental Stroke: In Vivo Evidence against an Antiexcitotoxic Mechanism , 1997, The Journal of Neuroscience.

[7]  T. Tsuruo,et al.  Interaction of cyclosporin derivatives with the ATPase activity of human P‐glycoprotein , 1997, British journal of pharmacology.

[8]  Yong Y. He,et al.  Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. , 1997, Stroke.

[9]  B. Siesjö,et al.  Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia , 1997, Brain Research.

[10]  S. Snyder,et al.  Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A , 1997, Nature Medicine.

[11]  J H Goodman,et al.  Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. , 1997, Cancer research.

[12]  J. Olson,et al.  Quantification and pharmacokinetics of blood-brain barrier disruption in humans. , 1996, Journal of neurosurgery.

[13]  J. Mcdonald,et al.  Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures , 1996, Annals of neurology.

[14]  J. Lemasters,et al.  Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. , 1996, Neuroscience.

[15]  S. Kuroda,et al.  Postischemic administration of FK506 reduces infarct volume following transient focal brain ischemia , 1996 .

[16]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[17]  M. Moeschberger,et al.  Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. , 1996, Neurosurgery.

[18]  S. Kuroda,et al.  Delayed Treatment with α-Phenyl-N-tert-butyl Nitrone (PBN) Attenuates Secondary Mitochondrial Dysfunction after Transient Focal Cerebral Ischemia in the Rat , 1996, Neurobiology of Disease.

[19]  Paolo Bernardi,et al.  The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal , 1996, Journal of bioenergetics and biomembranes.

[20]  H. Weiss,et al.  Increased Blood–Brain Permeability with Hyperosmolar Mannitol Increases Cerebral O2 Consumption and O2 Supply/Consumption Heterogeneity , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  G. Sutherland,et al.  The effect of mannitol on experimental cerebral ischemia, revisited. , 1996, Neurosurgery.

[22]  O. Lindvall,et al.  Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. , 1995, Acta physiologica Scandinavica.

[23]  Paul Antoine Salin,et al.  A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  M. Zoratti,et al.  The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[25]  H. Karibe,et al.  Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats. , 1995, Journal of neurosurgery.

[26]  I. Tamai,et al.  In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. , 1994, Biochemical pharmacology.

[27]  B. Siesjö,et al.  Delayed treatment with the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. , 1994, Acta physiologica Scandinavica.

[28]  S. Butcher,et al.  Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia , 1994, Nature.

[29]  T. Tsuruo,et al.  Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. , 1994, Biochimica et biophysica acta.

[30]  K. Tomizawa,et al.  Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat , 1994, Brain Research.

[31]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Duchen,et al.  On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. , 1993, Cardiovascular research.

[33]  J. Liu,et al.  FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. , 1993, Immunology today.

[34]  J. Liu.  FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. , 1993, Trends in pharmacological sciences.

[35]  Y. Shiga,et al.  Cyclosporin A protects against ischemia-reperfusion injury in the brain , 1992, Brain Research.

[36]  P. Weinstein,et al.  Effect of mannitol on local cerebral blood flow after temporary complete cerebral ischemia in rats. , 1992, Journal of neurosurgery.

[37]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[38]  I. Tamai,et al.  Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. , 1990, The Journal of biological chemistry.

[39]  T. Gunter,et al.  Mechanisms by which mitochondria transport calcium. , 1990, The American journal of physiology.

[40]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[41]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[42]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[43]  Yoji Yoshida,et al.  Experimental studies of ischemic brain edema , 1986 .

[44]  D. Bigner,et al.  Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. , 1985, Cancer research.

[45]  J. Biggs,et al.  Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation. , 1984, The New England journal of medicine.

[46]  Stanley I. Rapoport,et al.  Opening of the blood-brain barrier by acute hypertension , 1976, Experimental Neurology.